Reports of direct interactions between these proteins and EGF are not available, but it was shown before that SLC16A3 co-locates with CD147 in breast cancer cells11, which in turn is associated with EGFR in similar lipid domains12, suggesting that SLC16A3 resides in the neighborhood of EGFR at the cell surface13. This evidence concerns the gene EGF and breast cancer.